INSTRUCTIONAL DESIGN IN HEMA-PHARMACOLOGY

Attached is the instructional design for next week's pharma lecture. Pls prepare for an exam. Kindly share this email to the other sections.-MVRemudaro

Topic: PHARMACOLOGY
Student: 2nd YEAR
Venue:
Number of Hours: 4 hours
Schedule:
Module/unit Description: This module discusses drugs used in cytopenias and coagulation. Included are the drugs mechanisms of action, adverse effects and
clinical indications. Instructional activities include plenary lectures and case discussions.

Entry competencies: Background on basic cell and blood cell physiology and pathology

Learning Outcomes:
The course is geared towards enabling the second year medical students to achieve the following learning outcomes with their corresponding level of emphasis:

Learning Outcomes Level of emphasis

1 - Demonstrate clinical competence Demonstrated
2 - Communicate effectively Practiced
3 - Lead and manage health care teams Practiced
4 - Engage in research activities Practiced
5 - Demonstrate inter professionalism Introduced
6 - Utilize systems-based approach to healthcare Introduced
7 - Engage in continuing personal and professional development Practiced
8 - Adhere to ethical, professional and legal standards Practiced
9 - Demonstrate nationalism, internationalism and dedication to service Practiced
10 - Practice the principles of social accountability Introduced

1
Learning Objectives: At the end of the topic, the second year medical students should be able to:

Learning Objectives and Learning Content T-L Activities Resources Evaluation

Outcomes Addressed

Explain the pharmacokinetics and 1. Agents used in Plenary lecture Basic & clinical Written examination
pharmacodynamics of medications cytopenias pharmacology by Katzung - quiz
(1D ,2D, 4D,7D) - Agents used in Case discussion 13th edition - long exam – after
anemia Chapters 34-35 onco pharma
Correlate the mechanism of action of the - Hematopoietic lecture
drugs with the clinical disorders with which growth factors Physiology by Guyton Performance rating
they are indicated and anticipate the adverse 2. Drugs used in disorder Scale – 10%
reactions of coagulation - SGD & case
(1D ,2D, 4D, 7D) - Anticoagulants discussion –
- Fibrinolytic included in the
Collaborate as a - Antiplatelet agents onco pharma SGD
group demonstrating
the following attributes of
teamwork, cooperation, and diligence when
solving the assigned case/topic
(2D, 3P, 5D, 6P, 8D, 9P, 10P)
Submit and present a summary of the group
output
(3P, 5D, 8D, 9P, 10P)